Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

Green, M J, Matheson, S L, Shepherd, A, Weickert, C S, Carr, V J·2011·Molecular Psychiatry
DOI 10.1038/mp.2010.88

Cited by (453)

Items 401–453 of 453

  1. Intronic miRNA miR-3666 Modulates its Host Gene FOXP2 Functions in Neurodevelopment and May Contribute to Pathogenesis of Neurological Disorders Schizophrenia and Autism
    Abul Bashar Mir Md. Khademul Islam · 2017 · Journal of Applied Biotechnology & Bioengineering
  2. Búsqueda De Nuevos Biomarcadores De La Cognición En Esquizofrenia
    Rafael Penadés, Clemente García‐Rizo, Miquel Bioque, Alexandre González-Rodríguez, Bibiana Cabrera, Gisela Mezquida, Miquel Bernardo · 2015 · Schizophrenia Research Cognition
  3. BDNF–TrkB signaling as a therapeutic target in neuropsychiatric disorders
    Rachel Hill, Xin Du, YeeWen Candace Wu · 2014 · Journal of Receptor Ligand and Channel Research
  4. ‘Two Hit’ Neurodevelopmental Mechanisms in Schizophrenia: Focus on Animal Models and the Role of BDNF
    Maren Klug, Rachel Hill, Maarten van den Buuse · 2015 · Springer eBooks
  5. Neuroinflammation in Alzheimer's Disease
    2020 · Case Medical Research
  6. Exercise-induced time-dependent changes in plasma BDNF levels in people with schizophrenia
    VR Elsner, Laira Fuhr, Caroline Lavratti, I.R.V. Silva, GP Reinaldo, NO de Carvalho · 2018 · Journal of Novel Physiotherapy and Physical Rehabilitation
  7. Extracellular Vesicles from Peripheral Blood Mononuclear Cells of Hyperammonemic Rats Induce Neuroinflammation in Hippocampus, Impairing Memory and Learning in Normal Rats
    Paula Izquierdo‐Altarejos, Adrià López‐Gramaje, María A. Pedrosa, Valentina Evita Sebestyén, Lola Vazquez, Mar Martinez‐García, Marta Llansola, Vicente Felipo · 2025 · Journal of Neuroimmune Pharmacology
  8. State of Art of Serum Brain-Derived Neurotrophic Factor in Schizophrenia
    Davide Carlino, M. Baiano, Maurizio De, Enrico Tongiorgi · 2011 · InTech eBooks
  9. Dopaminergic activity and behaviour in SOCS2 transgenic mice: Revealing a potential drug target for schizophrenia
    Udani Ratnayake, Harleen S. Basrai, Ann M. Turnley, Maarten van den Buuse · 2014 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  10. Review article: CLINICAL PHARMACOLOGY OF ATYPICAL ANTIPSYCHOTICS: AN UPDATE
    Montserrat Maurí, Silvia Paletta, Michele Maffini, Alessandro Colasanti, Filippo Dragogna, Chiara Di Pace · 2014
  11. Myths of the Baltic Sea eutrophication
    Oleg Savchuk · 2018 · Journal of Aquaculture & Marine Biology
  12. Анализ гидролиза пептидов функционально важных участков мозгового и глиального нейротрофических факторов антителами больных шизофренией и другими нейроиммунными заболеваниями
    Evgeny A. Ermakov, Mark M. Melamud, Georgy A. Nevinsky, Valentina N. Buneva · 2023 · Сибирский вестник психиатрии и наркологии
  13. Psychogenic Non-epileptic Seizures: An Update on Diagnosis and Management
    Sandro Misciagna · 2024 · IntechOpen eBooks
  14. Evolution of BDNF Full-Length/Truncated Receptor Ratio and Cognitive/General Functioning After a First Episode of Psychosis
    Monica Martinez Cengotitabengoa, Susana Alberich, Mara Parellada, Bibiana Cabrera, Esther Berrocoso, Roberto Rodríguez–Jiménez, António Lobo, María Paz García‐Portilla, Miquel Bernardo, Juan Carlos Leza et al. · 2019 · Neuropsychiatry
  15. Are serum brain-derived neurotrophic factor concentrations related to brain structure and psychopathology in late childhood and early adolescence?
    Célia Maria de Araújo, Walter Swardfager, André Zugman, Hugo Cogo‐Moreira, Sintia Iole Belangero, Vanessa Ota, Letícia Spíndola, Hakon H. Hakonarson, Renata Pellegrino, Ary Gadelha et al. · 2019 · CNS Spectrums
  16. Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia
    Venus Vatankhah, Arash Mirabzadeh, Hamidreza Iranpour, Bahman Dieji, Mehdi Norouzi, Morteza Karimipour, Jaleh Nobakht, Elham Esmaeili, Maryam Ayazi · 2019 · Iranian Rehabilitation Journal
  17. Videogame training increases clinical well-being, attention and hippocampal-prefrontal functional connectivity in patients with schizophrenia
    Maxi Becker, Djo Fischer, Jürgen Gallinat, Simone Kühn · 2023 · Research Square
  18. Peripheral Biomarker Candidates in Schizophrenia
    Johannes Thome, Agnieszka Bratek, Krzysztof Krysta · 2014 · Advances in biological psychiatry
  19. The selfish brain
    Roger S. McIntyre · 2012 · Trends in Psychiatry and Psychotherapy
  20. Effect of treatment with atypical drugs for 6 months on brain levels of N-acetyl aspartate or serum levels of brain-derived neurotrophic factor in early-stage first-episode schizophrenia - a preliminary study
    Naoki Gotō, Reiji Yoshimura, Shingo Kakeda, Joji Nishimura, Junji Moriya, Kenji Hayashi, Hikaru Hori, Atsuko Ikenouchi, Wakako Umene‐Nakano, Asuka Katsuki et al. · 2011 · Clinical Neuropsychopharmacology and Therapeutics
  21. Tumour necrosis FA cTor - ALPHA mediAT ed mecHAnisms oF cogniT ive dysF unc Tion 1 Discipline of Psychiatry, School of Medicine,
    Bernhard Theodor Baune, Marie-Lou Camara, Harris A. Eyre, Magdalene C. Jawahar, Helen Anscomb, Heinrich Körner · 2012
  22. Central and peripheral molecular profiling of sex differences in schizophrenia, major depressive disorder, and controls
    Jordan M. Ramsey · 2015 · Apollo (University of Cambridge)
  23. Investigation of the genetic basis of schizophrenia and cognitive function
    Laura Whitton · 2019 · Arrow@dit (Dublin Institute of Technology)
  24. Veränderte kortikale Plastizität und Konnektivität bei psychisch nicht erkrankten erstgradigen Angehörigen von Patienten mit einer Schizophrenie
    Kristina Misewitsch · 2019
  25. Avaliação do efeito de antipsicóticos em cultura de oligodendrócitos humanos, através de análises de proteoma : Evaluating antipsychotics effects on a human oligodendrocyte culture, through proteome analyses
    Gabriela Seabra · 2019 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  26. SNPs associated with Schizophrenia: Evidence from Iranian patients
    Ali Molaei, Zahra Noormohammadi, Iman Salahshourifar, Niloufar Mahdavi Hezaveh · 2019 · Meta Gene
  27. BDNF - a probably common pathogenetic factor for schizophrenia and depressive episode
    Rinaldo Shishkov, Trifon Chervenkov · 2012 · Scripta Scientifica Medica
  28. Gross Pathology in Schizophrenia
    Matthew Roy Williams · 2021 · Springer eBooks
  29. Connections between social stress, immune dysregulation and psychosis
    Jacqueline Counotte · 2021
  30. Fingolimod ameliorates cognitive impairments in a phencyclidine-induced rat model of schizophrenia
    Tao Li, Xueli Yu, Xueyu Qi, Long Wei, Liansheng Zhao, Wei Deng, Wanjun Guo, Qiang Wang, Xiaohong Ma, Xun Hu et al. · 2022
  31. Faculty Opinions recommendation of Neuroinflammation in Alzheimer's disease.
    Daniela Perani · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  32. Plasma Biomarkers in Early-Onset Schizophrenia. Case-Control Study in Adolescent Population
    Przemyslaw Temistokles Zakowicz, Maria Skibińska, Filip Waśniewski, Bartosz Skulimowski, Joanna Pawlak · 2022 · Research Square
  33. ATIVIDADE FÍSICA E DESORDENS DE SAÚDE MENTAL: PREVENÇÃO, CUIDADO E TRATAMENTO
    Débora Duarte Honorio, Isabel de Miranda, Filipe Dinato de Lima · 2023 · Editora Científica Digital eBooks
  34. Study of Brain-derived Neurotrophic Factor in Drug-naive Patients with Schizophrenia
    Partik Kaur, V. S. Pal, Vijay Niranjan, Varchasvi Mudgal · 2024 · Archives of Medicine and Health Sciences
  35. Hyperprolactinemia in drug-naïve first episode psychosis and its association with BDNF levels
    Alba Toll, Daniel Bergé, Laura Martínez-Sadurní, Amira Trabsa, V Perez-Sola, Anna Mané · 2025 · The European Journal of Psychiatry
  36. A Literature Review and Preliminary Study on Proteomic Research Associated With the Therapeutic Mechanism and Efficacy of Electroconvulsive Therapy in Schizophrenia Patients
    Jh. Jang, Minah Kim, Dohyun Han, Won-Cheol Kim, Jun Soo Kwon · 2025 · Korean Journal of Schizophrenia Research
  37. The gut-brain axis: potential reshaping the future of anti-NMDAR encephalitis treatment
    Chuchu Shen, Yinyin Xie, Yi Xie, Lina Wang, Aoya Han, Xinru Zhou, Shijie Zhang, Xiangwan Fu, Nanchang Xie · 2025 · Frontiers in Immunology
  38. A Review of the Effects of Maternal and Paternal Obesity on Neurodevelopmental Disorders and Related Neurobiology in Rodent and Human Offspring
    Hannah Chadwick, Victorio Bambini-Júnior, Neil Dawson, Cheryl A. Hawkes · 2025 · Obesity Reviews
  39. Structural and functional cerebral changes in patients with schizophrenia and genetic risk-allele carriers
    Joseph P. Kambeitz · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  40. Additional file 1 of BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
    Betul Aslan Turkmen, Esra Yazıcı, Erdogan, Derya Guzel, Mehmet Akif Suda, Ahmet Bülent Yazıcı · 2021 · Figshare
  41. Additional file 1 of Suicide Reduction in Schizophrenia via Exercise (SUnRISE): study protocol for a multi-site, single-blind, randomized clinical trial of aerobic exercise for suicide risk reduction in individuals with schizophrenia
    Katie Beck-Felts, Marianne S. Goodman, Luz H. Ospina, Wall, Melanie, Joseph P. McEvoy, L. Fredrik Jarskog, Jacob S. Ballon, Matthew N. Bartels, Richard Buchsbaum, Richard P. Sloan et al. · 2020 · Figshare
  42. Could brain-derived neurotrophic factor, irisin, and peroxisome proliferator-activated receptor-gamma be a pathway in cognitive impairment in schizophrenia?
    Hasan Ünver, Evrim Bayrak Oruc, Ezel Yıldırım, Semih Ergişi, Ali Yalçındağ, Aysegul DAGDEVIREN, Sibel Örsel, Gamze Erzın · 2026 · BMC Psychiatry
  43. Proteo-metabolomic approaches in CNS drug discovery: New avenues for psychiatric disorders
    S. Sridevi, S. Nirenjen, Rukaiah Fatma Begum, N. Afreen, Bhupendra G. Prajapati, Rapuru Rushendran, S. (Shankar) Singh · 2026 · Advances in protein chemistry and structural biology
  44. Epigenetic regulation of BDNF-TRKB signaling in the pathophysiology and treatment of mood disorders
    Fabien Boulle · 2013 · theses.fr (ABES)
  45. Changes in serum Nogo-A and BDNF levels following treatment in drug-naive first-episode schizophrenia: A naturalistic prospective study
    Burcu Besim Dudaklı, Helin Kan Uzel, Mahmut Safa Ocak, Makbule Esen Öksüzoğlu, Zeynep Cirakli, Nesrin Karamustafalıoğlu · 2026 · Psychiatry Research
  46. Altérations cérébrales structurales et fonctionnelles spécifiques des hallucinations auditives résistantes chez les patients atteints de schizophrénie
    Marion Psomiades · 2017 · theses.fr (ABES)
  47. Endothélium, inflammation et cognition : focus sur le BDNF
    Martin Pédard · 2018 · theses.fr (ABES)
  48. Extracts of Coriaria nepalensis ameliorate MK-801-induced schizophrenia-like behaviors via regulation of neurotransmitter imbalance and neuroinflammation
    Min Tan, Yuan-Yuan Hu, Xin-Ye Du, Yu-Rui Yang, Ran Hong, Zhi-Jun Zhang, Rong-Tao Li · 2026 · Journal of Ethnopharmacology
  49. Systems pharmacology and translational insights into herbal therapeutics for schizophrenia: Mechanistic advances, network-based approaches, and future directions
    Anjali Tripathi, Anand Gaurav, Vinay Kumar Pandey, Ayaz Mukarram Shaikh, Béla Kovács · 2026 · Journal of Pharmacological Sciences
  50. The BDNF-mediated association between NGAL and cognitive function in drug-naïve schizophrenia
    Zhenning Feng, Xue Li, Xiaoshan Zhai, Yuying Qiu, Xiaoxiao Sun, Qiao Su, Ying Xu, Fuyou Bi, Meijuan Li, Jie Li · 2026 · Journal of Neural Transmission
  51. Beyond diagnostic boundaries: Evaluating neurocognitive and biomarker profiles in the psychosis spectrum based on Schneiderian first-rank symptoms
    Tugay Elik, Ece Özlem Öztürk, Aybike Ecmel Cinkara, Fatma Taneli, Ömer Aydemır, Ayşen Esen Danacı · 2026 · Journal of Psychiatric Research
  52. Neuronal IL-18 Signaling in the Medial Habenula Contributes to Schizophrenia-Like Behavioral Deficits via ERK-Associated BDNF Suppression
    Dongjie Sun, Chi Zhang, Menghui Hou, Hua Zhao · 2026 · Molecular Neurobiology
  53. Redox compromise as an early, modifiable entry point in schizophrenia: a staging framework for early intervention
    Leonard A. Lado, Aruna Misir · 2026 · Frontiers in Neuroscience